Visual function and quality of life in patients with Stevens-Johnson syndrome who received acute protocol-based ocular care

Visual function and quality of life in patients with Stevens-Johnson syndrome who received acute protocol-based ocular care

Purpose: To report visual function and quality of life (VF/QOL) using the National Eye Institute Visual Function Questionnaire (NEI-VFQ-25) and the ocular surface disease index (OSDI) in patients in the chronic phase of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN).Methods: The NEI-V...

Full description

Bibliographic Details
Main Authors:	Swapna S. Shanbhag, Mohammad A. Tahboub, James Chodosh, Hajirah N. Saeed
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Toxicology
Subjects:	stevens-johnson syndrome (SJS) toxic epidermal necrolysis (TEN) visual function national eye institute visual function questionnaire (NEI-VFQ-25) ocular surface disease index (OSDI)
Online Access:	https://www.frontiersin.org/articles/10.3389/ftox.2022.992696/full

Similar Items

An alternative model for assessing mortality risk in Stevens Johnson syndrome/toxic epidermal necrolysis using a random forests classifier: A pilot study
by: Omar Shareef, et al.
Published: (2022-12-01)

Stevens-Johnson syndrome and toxic epidermal necrolysis in pregnant patients: A systematic review
by: Ajay N. Sharma, BS, et al.
Published: (2020-09-01)

Disease severity and status in Stevens–Johnson syndrome and toxic epidermal necrolysis: Key knowledge gaps and research needs
by: Rannakoe J. Lehloenya, et al.
Published: (2022-09-01)

Editorial: Stevens Johnson syndrome: past, present, and future directions
by: Hajirah N. Saeed, et al.
Published: (2024-03-01)

Clinicoetiological study of Stevens-Johnson syndrome and toxic epidermal necrolysis spectrum and the correlation of SCORTEN with prognosis
by: Amuthavalli Kanagarajan, et al.
Published: (2023-01-01)

Severe ocular complications of SJS/TEN and associations among pre-onset, acute, and chronic factors: a report from the international ophthalmology collaborative group
by: Mayumi Ueta, et al.
Published: (2023-06-01)

Scoring Assessments in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
by: Allison S. Dobry, et al.
Published: (2022-06-01)

A Retrospective Study: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
by: Yuli Wahyu Rahmawati, et al.
Published: (2016-10-01)

A case of Stevens-Johnson syndrome treated with oral cyclosporine
by: Victoria Griffith, et al.
Published: (2023-01-01)

A Review of the Systemic Treatment of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
by: Hua-Ching Chang, et al.
Published: (2022-08-01)

Genitourinary management and follow-up for patients with Stevens-Johnson syndrome/toxic epidermal necrolysis
by: Gina T. Baaklini, et al.
Published: (2023-04-01)

Ophthalmic Aspects of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Narrative Review
by: Gábor Tóth, et al.
Published: (2023-05-01)

Syndroma Stevens-Johnson - toxic epidermal necrolysis overlap associated with carbamazepine in patient with secondary epilepsy caused by brain tumor (Glioblastoma multiforme)
by: Vojvodić A., et al.
Published: (2015-01-01)

Causes of Drug-Induced Severe Cutaneous Adverse Reaction Epidermal Necrolysis (EN): An Analysis Using FDA Adverse Event Reporting System (FAERS) Database
by: Fei W, et al.
Published: (2023-08-01)

A retrospective analysis of infections and antibiotic treatment in patients with Stevens–Johnson syndrome and toxic epidermal necrolysis
by: Min Diao, et al.
Published: (2020-01-01)

Case report: Alpelisib-induced Stevens–Johnson syndrome
by: Christine Jane Kurian, et al.
Published: (2022-09-01)

Cyclosporine monotherapy in pediatric Stevens–Johnson syndrome and toxic epidermal necrolysis: Preserving sepsis indicators while promoting recovery
by: Simran S Tuli, et al.
Published: (2023-01-01)

Stevens Johnson syndrome and toxic epidermal necrolysis – an Australian analysis of treatment outcomes and mortality
by: Alain Khoi Tran, et al.
Published: (2019-10-01)

Ocular surface involvement and histopathologic changes in the acute stage of Stevens-Johnson syndrome and toxic epidermal necrolysis: a cross-sectional study
by: Yingyi Liu, et al.
Published: (2023-07-01)

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Should Be Kept in Mind in Children with Febrile Neutropenia, Oral Cavity Lesions, and Skin Rash
by: Eda Ataseven, et al.
Published: (2016-05-01)

Daunorubicin induced Stevens‐Johnson syndrome: A case report
by: Preeti Shakya, et al.
Published: (2021-07-01)

The Profiles of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) Patients in Tertiary Hospital
by: William Andrew Isaac, et al.
Published: (2021-07-01)

Stevens-Johnson syndrome/toxic epidermal necrolysis overlap triggered by ethosuximide: a rare pediatric report
by: Sandra Soares-Cardoso, et al.
Published: (2023-04-01)

Ventilatory support in Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis
by: Kevin Phan, et al.
Published: (2022-01-01)

Ocular manifestations in acute stage Stevens-Johnson syndrome/toxic epidermal necrolysis - A retrospective study in a tertiary hospital in south India
by: Thanuja Gopal Pradeep, et al.
Published: (2022-01-01)

Biologic TNF-alpha inhibitors in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a systemic review
by: Shan Zhang, et al.
Published: (2020-01-01)

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management
by: Robert Frantz, et al.
Published: (2021-08-01)

Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study
by: Loraine L. W. Chow, et al.
Published: (2017-05-01)

Investigation of Monnose-Binding Lectin gene Polymorphism in Patients with Erythema Multiforme, Stevens-Johnson Syndrome and Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Syndrome
by: Sevil Toka, et al.
Published: (2012-09-01)

Pemphigus vulgaris mimicking Steven-Johnson syndrome/toxic epidermal necrolysis: report of an unusual case
by: Latifah Albrahim, et al.
Published: (2023-05-01)

Dermatological adverse drug reactions with particular reference to Steven-Johnson syndrome and toxic epidermal necrolysis
by: Muddasir Sharief Banday, et al.
Published: (2023-01-01)

Gambaran Klinis Steven Johnson Syndrome dan Toxic Epidermal Necrolysis pada Pasien Anak
by: Annisa Fitriana, et al.
Published: (2018-09-01)

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis, A Review of Pathogenesis, Clinical Features, Diagnosis and Treatment
by: Martyna Rozenbajgier, et al.
Published: (2022-09-01)

Oxcarbazepine-induced stevens johnson syndrome and toxic epidermal necrolysis overlap
by: Sangha Mitra Godi, et al.
Published: (2022-01-01)

Genetic Markers and Danger Signals in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
by: Wen-Hung Chung, et al.
Published: (2010-01-01)

Emerging Insights into Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor and Tumor-Targeted Therapy
by: Lin M, et al.
Published: (2024-04-01)

Photodistributed Stevens–Johnson syndrome and toxic epidermal necrolysis: a systematic review and proposal for a new diagnostic classification
by: Blake Jeffrey McKinley, et al.
Published: (2023-06-01)

Stevens–Johnson syndrome and toxic epidermal necrolysis: A fresh look at an old foe
by: Sowmya Kaimal, et al.
Published: (2023-01-01)

Biologic TNF-α Inhibitors for Stevens–Johnson Syndrome, Toxic Epidermal Necrolysis, and TEN-SJS Overlap: A Study-Level and Patient-Level Meta-Analysis
by: Jiali Cao, et al.
Published: (2023-05-01)

Analysis of clinical features of oxcarbazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis
by: Qingzi Yan, et al.
Published: (2023-10-01)